The short answer: there is no official US maker’s list price for this medicine. Ask for the full written cost of the care being offered.
The honest price answer
As of September 28, 2026, thymosin alpha-1 has no approved US product. There is no US manufacturer list price or government price for it to report.
A figure on a care offer is a quote for that offer. Ask what it includes before using it to compare options.
What the price record means
An advertised price cannot answer the pharmacy question
Without an approved US product, there is no list price from a US maker. An offer of a medicine made by a pharmacy or brought from another country does not create that price.
How will the charges change if I leave the visit without a prescription?
What are the cancellation and refund terms?
Compare the same parts of each offer
Put the visit, tests, medicine, delivery and follow-up on separate lines. Ask whether the quoted amount is an opening offer or the ongoing charge. Keep the written answer beside the cancellation terms.
A cheaper quote leaves other questions open
As of September 26, 2026, the rules about which raw ingredients a pharmacy may use still apply, whatever the price. An advertised low price gives no permission for a pharmacy to make the medicine.
A short note to send or read aloud
“Please give me the full cost before I commit.”
“Please separate the visit, tests, product, delivery and follow-up.”
“Please explain any recurring charge and how I can end it.”